| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2002 | WO2002051449A2 Composition and process for bone growth and repair |
| 07/04/2002 | WO2002051444A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | WO2002051439A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051437A1 Induction of tolerance |
| 07/04/2002 | WO2002051436A2 Stable enzymatic wound debrider |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051433A2 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 07/04/2002 | WO2002051432A1 A novel pharmaceutical compound and methods of making and using same |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051429A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 07/04/2002 | WO2002051426A2 Compositions and methods for treating sexual dysfunction, enhancing sexual function, increasing testosterone levels, and improving muscle strength and mass |
| 07/04/2002 | WO2002051407A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 07/04/2002 | WO2002051390A2 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
| 07/04/2002 | WO2002051389A2 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | WO2002051386A2 Lipid microparticles by cryogenic micronization |
| 07/04/2002 | WO2002051352A2 New uses of insulin and pancreatin |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002033042A3 Recombinant antibody fragments as autoantibody antagonists |
| 07/04/2002 | WO2002030351A3 Improvement of graft acceptance through manipulation of thymic regeneration |
| 07/04/2002 | WO2002030259A3 Disease prevention by reactivation of the thymus |
| 07/04/2002 | WO2002029023A8 Nicastrin protein |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002025279A3 Use of amyloid precursor protein for treating brain amyloidosis |
| 07/04/2002 | WO2002024877A3 Regulation of human pristanoyl-coa oxidase-like enzyme |
| 07/04/2002 | WO2002020609A3 Interleukin-11 for the treatment of stroke and neuropathies |
| 07/04/2002 | WO2002018626A8 Modulators of the interaction between arp2/3 and cortactin or hs-1 |
| 07/04/2002 | WO2002017968A9 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain-2 |
| 07/04/2002 | WO2002017898A3 Compositions and methods for inducing vasorelaxation |
| 07/04/2002 | WO2002012439A8 Genes associated with renal disease |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2002000700A3 Regulation of human p2y8-like g protein-coupled receptor |
| 07/04/2002 | WO2002000677A8 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001096535A3 Nucleic acid coding for a bonding site of a protein kinase of the mitogenic signalling cascade of a glycolysis-catalysing enzyme |
| 07/04/2002 | WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001089557A3 Methods for preventing strokes by inducing tolerance to e-selectin |
| 07/04/2002 | WO2001085793A3 G protein-coupled receptors |
| 07/04/2002 | WO2001081414A3 Integrin alpha subunit and uses thereof |
| 07/04/2002 | WO2001077175A3 G protein-coupled receptors |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001057207A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001053456A8 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001046420A8 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 07/04/2002 | WO2001042470A9 Nucleic acid and protein expressed thereby and their involvement in stress |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/04/2002 | WO2001032841A9 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 07/04/2002 | WO2001030813A9 Novel molecules of the card-related protein family and uses thereof |
| 07/04/2002 | WO2001030374A9 Stem cell engraftment-enhancing cellular proteins and their uses |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000073316A3 Virus immunologic determinants |
| 07/04/2002 | WO2000069909A9 Isolation and characterization of epidermal growth factor related protein |
| 07/04/2002 | WO2000069900A9 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020088019 Methods of and pharmaceutical compositions for improving implantation of embryos |
| 07/04/2002 | US20020088014 Minimal adenovirus mediated recombinant vaccine |
| 07/04/2002 | US20020086988 Polypeptide for use as tools in human therapeutics and diagnostics |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086984 Nucleotide sequences coding preferential polypeptides for use in the detection, prevention and treatment of microorganismal infection |
| 07/04/2002 | US20020086982 Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor |
| 07/04/2002 | US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086976 Peptide for use in the treatment of autoimmune disease |
| 07/04/2002 | US20020086975 P2u2 receptor antibodies |
| 07/04/2002 | US20020086971 Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content |
| 07/04/2002 | US20020086880 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 07/04/2002 | US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
| 07/04/2002 | US20020086844 Methods and reagents to regulate apoptosis |
| 07/04/2002 | US20020086843 Derived from human brain and possessing natriuretic activity; treating edema, hypertension, congestive heat failure, and acute and chronic renal failure |
| 07/04/2002 | US20020086841 Naked DNA construct encoding a cytokine selected from macrophage inflammatory protein-1 alpha, monocyte chemoattractant protein 1, and tumor necrosis factor-alpha, linked to a viral transcription control sequence, and carrier |
| 07/04/2002 | US20020086840 Use of Rad51 inhibitors for p53 gene therapy |
| 07/04/2002 | US20020086839 Inhibitors of DNA immunostimulatory sequence activity |
| 07/04/2002 | US20020086838 Such as antibodies, proteins, drugs such as spironolactone, imidapril, an angiotensin converting enzyme inhibitor, captopril, enalapril, defibrotide, and angiotensin II receptor antagonist |
| 07/04/2002 | US20020086836 Cftr gene regulator |
| 07/04/2002 | US20020086832 Immunosuppressing a human after allogenic cell, tissue or organ transplantation by administering a caspase-8 inhibitor |
| 07/04/2002 | US20020086831 Methods and use of motoneuronotrophic factors |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086829 Peptide and plurality of linked ligands that together form a water insoluble complex |
| 07/04/2002 | US20020086828 Uses for amino acid anticonvulsants |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086824 Novel methods and reagents for the treatment of osteoarthritis |